195
Views
2
CrossRef citations to date
0
Altmetric
Review

Low vision rehabilitation: current perspectives

, , &
Pages 53-58 | Published online: 20 Aug 2015

References

  • Raasch TW, Leat SJ, Kleinstein RN, Bullimore MA, Cutter GR. Evaluating the value of low-vision services. J Am Optom Assoc. 1997;68(5):287–295.
  • Resnikoff S, Pascolini D, Etya’ale D, et al. Global data on visual impairment in the year 2002. Bull World Health Organ. 2004;82(11):844–851.
  • Bourne RR, Stevens GA, White RA, et al. Causes of vision loss worldwide, 1990–2010: a systematic analysis. Lancet Global Health. 2013;1(6):e339–e349.
  • Pascolini D, Mariotti SP. Global estimates of visual impairment: 2010. Br J Ophthalmol. 2012;96(5):614–618.
  • Stevens GA, White RA, Flaxman SR, et al. Global prevalence of vision impairment and blindness magnitude and temporal trends, 1990–2010. Ophthalmology. 2013;120(12):2377–2384.
  • Sánchez Ferreiro AV, Miguéns Vázquez X. Letter to the editor. Visual rehabilitation in low vision. Arch Soc Esp Oftalmol. 2013;88(3):123–124.
  • Brody BL, Gamst AC, Williams RA, et al. Depression, visual acuity, comorbidity, and disability associated with age-related macular degeneration. Ophthalmology. 2011;108(10):1893–1900.
  • Horowitz A, Reinhardt JP, Boerner K, Travis LA. The influence of health, social support quality and rehabilitation on depression among disabled elders. Aging Ment Health. 2003;7(5):342–350.
  • Rubin G. Vision rehabilitation for patients with age related macular degeneration. Eye. 2001;15 Part 3:430–435.
  • Crossland MD, Macedo AF, Rubin GS. Electronic books as low vision aids. Br J Ophthalmol. 2010;94(8):1109.
  • Crossland MD, Rui SS, Macedo AF. Smartphone, tablet computer and e-reader use by people with vision impairment. Ophthalmic Physiol Opt. 2014;34(5):552–557.
  • Gill K, Mao A, Powell AM, Sheidow T. Digital reader vs print media: the role of digital technology in reading accuracy in age-related macular degeneration. Eye. 2013;27(5):639–643.
  • TapTapSee. Available from: http://www.taptapseeapp.com/. Accessed June 8, 2015.
  • VizWiz. Available from: http://www.vizwiz.org/. Accessed June 8, 2015.
  • Optelec. Available from: http://www.optelec.com/. Accessed June 8, 2015.
  • Walker R. An iPad app as a low-vision aid for people with macular disease. Br J Ophthalmol. 2013;97(1):110–111.
  • Peli E. Vision multiplexing: an engineering approach to vision rehabilitation device development. Optom Vis Sci, 2001;78(5):304–315.
  • Vargas-Martin F, Peli E. Augmented-view for restricted visual field: multiple device implementations. Optom Vis Sci. 2002;79(11):715–723.
  • Peli E, Luo G, Bowers A, Rensing N. Applications of augmented vision head-mounted systems in vision rehabilitation. J Soc Inf Disp. 2007;15(12):1037–1045.
  • Luo G, Peli E. Development and evaluation of vision rehabilitation devices. Presented at the 33rd Annual International Conference of the IEEE EMBS, Boston, MA, USA, August 30 to September 3, 2011.
  • Massof RW, Rickman DL. Obstacles encountered in the development of the low vision enhancement system. Optom Vis Sci. 1992;69(1):32–41.
  • Culham LE, Chabra A, Rubin GS. Clinical performance of electronic, head-mounted, low-vision devices. Ophthalmic Physiol Opt. 2004;24(4):281–290.
  • Hwang AD, Peli E. Augmented edge enhancement for vision impairment using Google Glass. Optom Vis Sci. 2014;91(8):1021–1030.
  • Ianchulev T, Minckler DS, Hoskins HD, et al. Wearable technology with head-mounted displays and visual function. JAMA. 2014;312(17):1799–1801.
  • Tarita-Nistor L, Gonzalez EG, Mandelcorn MS, Lillakas L, Steinbach MJ. Fixation stability, fixation location and visual acuity after successful macular hole surgery. Invest Ophthalmol Vis Sci. 2009;50(1):84–89.
  • Gonzalez EG, Tarita-Nistor L, Mandelcorn ED, Mandelcorn M, Steinbach MJ. Fixation control before and after treatment for neovascular age-related macular degeneration. Invest Ophthalmol Vis Sci. 2011;52(7):4208–4213.
  • Tarita-Nistor L, Gonzalez EG, Markowitz SN, Steinbach MJ. Fixation characteristics of patients with macular degeneration recorded with the MP-1 microperimeter. Retina. 2008;28(1):125–133.
  • Crossland MD, Culham LE, Rubin GS. Fixation stability and reading speed in patients with newly developed macular disease. Ophthalmic Physiol Opt. 2004;24(4):327–333.
  • Schuchard RA. Preferred retinal loci and macular scotoma characteristics in patients with age-related macular degeneration. Can J Ophthalmol. 2005;40(3):303–312.
  • Contestabile MT, Recupero SM, Palladino D, et al. A new method of biofeedback in the management of low vision. Eye. 2002;16(4):472–480.
  • Giorgi D, Contestabile MT, Pacella E, Balacco Gabrieli C. An instrument for biofeedback applied to vision. Appl Psychophysiol Biofeedback. 2005;30(4):389–395.
  • Morales MU, Saker S, Amoaku WM. Bilateral eccentric vision training on pseudovitelliform dystrophy with microperimetry biofeedback. BMJ Case Rep. 2015;2015:bcr2014207969.
  • Vingolo EM, Cavarretta S, Domanico D, Parisi F, Malagola R. Microperimetric biofeedback in AMD patients. Appl Psychophysiol Biofeedback. 2007;32(3–4):185–189.
  • Vingolo EM, Salvatore S, Cavarretta S. Low-vision rehabilitation by means of MP-1 biofeedback examination in patients with different macular diseases: a pilot study. Appl Psychophysiol Biofeedback. 2009;34(2):127–133.
  • Nistor LT, Gonzalez EG, Markowitz SN, Steinbach MJ. Plasticity of fixation in patients with central vision loss. Vis Neurosci. 2009;26(5–6):487–494.
  • Grenga PL, Trabucco P, Meduri A, Fragiotta S, Vingolo EM. Microperimetric biofeedback in a patient with oculocutaneous albinism. Can J Ophthalmol. 2013;48(5):e105–e107.
  • Vingolo EM, Salvatore S, Domanico D, Spadea L, Nebbioso M. Visual rehabilitation in patients with myopic maculopathy: our experience. Can J Ophthalmol. 2013;48(5):438–442.
  • Verboschi F, Domanico D, Nebbioso M, Corradetti G, Scalinci SZ, Vingolo EM. New trends in visual rehabilitation with MP-1 microperimeter biofeedback: optic neural dysfunction. Funct Neurol. 2013;28(4):285–291.
  • Toto L, Di Antonio L, Mastropasqua A, De Nicola C, Mastropasqua L. Rehabilitation with MP1 biofeedback training of a posterior microphthalmos case. Can J Ophthalmol. 2013;48(5):e107–e111.
  • Sabel BA, Kasten E. Restoration of vision by training of residual functions. Curr Opin Ophthalmol. 2000;11(6):430–436.
  • Sabel BA, Kenkel S, Kasten E. Vision restoration therapy (VRT) efficacy as assessed by comparative perimetric analysis and subjective questionnaires. Restor Neurol Neurosci. 2004;22(6):399–420.
  • Vingolo EM, Salvatore S, Grenga P, Limoli PG. . Visual training in retinitis pigmentosa patients: neural plasticity and function recovery. In: Catlin RB, editor. Retinal Degeneration: Causes, Diagnosis and Treatment. New York, NY, USA: Nova Publisher; 2009.
  • Vingolo EM, Salvatore S, Limoli PG. MP-1 Biofeedback: luminous pattern stimulus versus acoustic biofeedback in age related macular degeneration (AMD). Appl Psychophysiol Biofeedback. 2013;38(1):11–16.
  • Baker CI, Peli E, Knouf N, Kanwisher NG. Reorganization of vision processing in macular degeneration. J Neurosci. 2005;25(3):614–618.
  • Baker CI, Dilks DD, Peli E, Kanwisher NG. Reorganization of visual processing in macular degeneration: replication and clues about the role of foveal loss. Vision Res. 2008;48(18):1910–1919.
  • Amore FM, Paliotta S, Silvestri V, Piscopo P, Turco S, Reibaldi A. Biofeedback stimulation in patients with age-related macular degeneration: comparison between 2 different methods. Can J Ophthalmol. 2013;48(5):431–437.
  • Humayun MS, Dorn JD, da Cruz L, et al. Interim results from the International Trial of Second Sight’s visual prosthesis. Ophthalmology. 2012;119(4):779–788.
  • Zrenner E, Bartz-Schmidt KU, Benav H, et al. Subretinal electronic chips allow blind patients to read letters and combine them to words. Proc Biol Sci. 2011;278(1711):1489–1497.
  • Chen SJ, Mahadevappa M, Roizenblatt R, Weiland J, Humayun M. Neural responses elicited by electrical stimulation of the retina. Trans Am Ophthalmol Soc. 2006;104:252–259.
  • Ahuja AK, Dorn JD, Caspi A, et al. Blind subjects implanted with the Argus II retinal prosthesis are able to improve performance in a spatial-motor task. Br J Ophthalmol. 2011;95(4):539–543.
  • Dorn JD, Ahuja AK, Caspi A, et al. The detection of motion by blind subjects with the Epiretinal 60-Electrode (Argus II) retinal prosthesis blind subjects and motion detection. JAMA Ophthalmol. 2013;131(2):183–189.
  • Marc RE, Jones BW, Anderson JR, et al. Neural reprogramming in retinal degeneration. Invest Ophthalmol Vis Sci. 2007;48(7):3364–3371.
  • da Cruz L, Coley BF, Dorn J, et al. The Argus II epiretinal prosthesis system allows letter and word reading and long-term functions in patients with profo vision loss. Br J Ophthalmol. 2013;97(5):632–636.